Macro Group Pharmaceuticals (Macro Capital) S.A.E

CASE:MCRO Voorraadrapport

Marktkapitalisatie: ج.م1.2b

Macro Group Pharmaceuticals (Macro Capital)E Balans Gezondheid

Financiële gezondheid criteriumcontroles 1/6

Macro Group Pharmaceuticals (Macro Capital)E has a total shareholder equity of EGP27.4M and total debt of EGP243.8M, which brings its debt-to-equity ratio to 891.5%. Its total assets and total liabilities are EGP517.5M and EGP490.1M respectively.

Belangrijke informatie

891.5%

Verhouding schuld/eigen vermogen

ج.م243.82m

Schuld

Rente dekkingsration/a
Contantج.م107.28m
Aandelenج.م27.35m
Totaal verplichtingenج.م490.14m
Totaal activaج.م517.49m

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Analyse van de financiële positie

Kortlopende schulden: MCRO's short term assets (EGP415.3M) do not cover its short term liabilities (EGP457.3M).

Langlopende schulden: MCRO's short term assets (EGP415.3M) exceed its long term liabilities (EGP32.9M).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: MCRO's net debt to equity ratio (499.2%) is considered high.

Schuld verminderen: Insufficient data to determine if MCRO's debt to equity ratio has reduced over the past 5 years.

Schuldendekking: MCRO's operating cash flow is negative, therefore debt is not well covered.

Rentedekking: Insufficient data to determine if MCRO's interest payments on its debt are well covered by EBIT.


Balans


Ontdek gezonde bedrijven